Bexicaserin
Bexicaserin (LP352) is a 5-HT2C receptor agonist with potential for studying obesity and psychiatric-related disorders (such as epilepsy) [1][2].
Product Specifications
CAS Number
2035818-24-5
Product Name Alternative
LP352
UNSPSC
12352005
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bexicaserin.html
Purity
99.96
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC(F)CNC(C1=C2C3=C(C=C1)CNCCN3C[C@@H]2C)=O
Molecular Formula
C15H19F2N3O
Molecular Weight
295.33
References & Citations
[1]Pędzich BD, et al. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice. Neuropsychopharmacology. 2022 Jun;47 (7) :1304-1314.|[2]Kaye R, et al. Searching for safer and more effective medications in the management of seizure disorders: a 5-HT2C superagonist[C]//EPILEPSIA. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2023, 64: 315-315.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
5-HT2 Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
